| abstract |
The present invention provides a novel erythromycin derivative having antibacterial activity against gram positive bacteria and gram negative bacteria. Use of the following compounds and their acid addition salts: 2,3-didehydro-11,12-dideoxy-3-de [(2,6-dideoxy-3-C-methyl-3-O-methyl) -Alpha-L-ribo-hexopyranosyl) oxy] -6-O-methyl-12,11- [oxycarbonyl [[4- [4- (3-pyridinyl) -1H-imidazol-1-yl] butyl] imino ]]-Erythromycin. [Selection figure] None |